JTC Employer Solutions Trustee Ltd Sells 1,107 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

JTC Employer Solutions Trustee Ltd trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 50.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,107 shares of the financial services provider’s stock after selling 1,107 shares during the quarter. JTC Employer Solutions Trustee Ltd’s holdings in iShares Biotechnology ETF were worth $146,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. BNP Paribas Financial Markets grew its holdings in iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the last quarter. Commerce Bank lifted its position in shares of iShares Biotechnology ETF by 1.8% in the 3rd quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after purchasing an additional 12,921 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. Main Management ETF Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 2.5% in the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after purchasing an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $18,476,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.4 %

Shares of NASDAQ IBB traded down $0.59 during midday trading on Monday, reaching $132.14. The stock had a trading volume of 575,268 shares, compared to its average volume of 1,319,654. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The company’s 50 day moving average price is $137.95 and its 200 day moving average price is $141.99.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.